D-0229-2022 Class II Terminated

Recalled by Ascend Laboratories LLC — Parsippany, NJ

FDA drug recall D-0229-2022 was initiated by Ascend Laboratories LLC on Nov 3, 2021 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Dec 21, 2022). Affected quantity: 4104 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 17, 2021
Initiation Date
Nov 3, 2021
Termination Date
Dec 21, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4104 bottles

Product description

Cefixime Capsules 400 mg, 50 capsules bottles, Rx Only, Manufactured by: Alken Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054 NDC 67877-584-50

Reason for recall

Failed Impurities/Degradation Specifications

Distribution pattern

Nationwide

Code information

Lot 20140282, exp Dec 2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0229-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0229-2022. Report a data issue: hello@regdatalab.com.